Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

WZ4002

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Dana-Farber Cancer Institute

Drug class:

EGFR inhibitor

Related drugs:

‹

cetuximab (347)

osimertinib (301)

erlotinib (235)

gefitinib (194)

panitumumab (123)

lapatinib (107)

neratinib (102)

brigatinib (50)

aumolertinib (39)

amivantamab-vmjw (25)

firmonertinib (14)

mobocertinib (12)

lazertinib (12)

tarloxotinib bromide (7)

nimotuzumab (6)

rociletinib (5)

tomuzotuximab (4)

necitumumab (3)

befotertinib (3)

ABP 494 (cetuximab biosimilar) (1)

BAY 2927088 (1)

Compound 6a (1)

abivertinib (1)

STI-001 (cetuximab biosimilar) (0)

antroquinonol (0)

zalutumumab (0)

JNJ-26483327 (0)

PF-08046052 (0)

rindopepimut (0)

Undisclosed EGFR inhibitor (0)

cetuximab biosimilar (0)

PF-06747775 (0)

JNJ-64041757 (0)

›

EGFR C797S	Non Small Cell Lung Cancer	EGFR C797S	Non Small Cell Lung Cancer	WZ4002 Resistant: C3 – Early Trials WZ4002 Resistant : C3	WZ4002 Resistant: C3 – Early Trials WZ4002 Resistant : C3
EGFR T790M	Non Small Cell Lung Cancer	EGFR T790M	Non Small Cell Lung Cancer	WZ4002 Sensitive: C3 – Early Trials WZ4002 Sensitive : C3	WZ4002 Sensitive: C3 – Early Trials WZ4002 Sensitive : C3
HER-2 L755P	Non Small Cell Lung Cancer	HER-2 L755P	Non Small Cell Lung Cancer	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D
HER-2 L755S	Gastric Cancer	HER-2 L755S	Gastric Cancer	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D
HER-2 L755S	Breast Cancer	HER-2 L755S	Breast Cancer	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D
HER-2 T798M	Breast Cancer	HER-2 T798M	Breast Cancer	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D
HER-2 L755P	Breast Cancer	HER-2 L755P	Breast Cancer	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D	WZ4002 Sensitive: D – Preclinical WZ4002 Sensitive : D